A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer

NCT03013712 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer
Esophageal Carcinoma
Pancreatic Cancer
Prostate Cancer
Gastric Cancer
Hepatic Carcinoma

Interventions

BIOLOGICAL: CAR-T cell immunotherapy

Sponsor

First Affiliated Hospital of Chengdu Medical College